Primidone BE study for USFDA submission [Regulatives / Guidelines]

posted by Ramesh Ramalingam  – India, 2018-04-09 07:54 (2403 d 17:24 ago) – Posting: # 18654
Views: 4,971

Dear All,

Till now, USFDA has not issued product specific bioequivalence recommendation to conduct the Primidone BE study. Any one could suggest, what to estimate in the Primidone BE study for USFDA submission, Whether required to estimate parent (Primidone) and metabolite Phenobarbital and phenylethylmalonamide (PEMA) or parent only?


Regards,
Ramesh.R


Edit: Relax; see also this post #9. I deleted your other post which is less than two days old… [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,288 posts in 4,890 threads, 1,659 registered users;
71 visitors (0 registered, 71 guests [including 11 identified bots]).
Forum time: 00:19 CET (Europe/Vienna)

‘Normal science’ means research firmly based upon one or more
past scientific achievements, achievements that some particular
scientific community acknowledges for a time as supplying
the foundation for its further practice.    Thomas S. Kuhn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5